| Company/Division name | FUJIFILM Diosynth Biotechnologies |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 680 |
| Year reshoring announced: | 2024 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 1200 |
| Country(ies) from which reshored: | Japan |
| City reshored to: | Holly Springs |
| State(s) reshored to: | NC |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | biotech, pharma |
| What domestic positive factors made reshoring more attractive? | Infrastructure, Skilled workforce availability/training, U.S. price of natural gas/chemicals/electricity |
